MAUDE Adverse Event Report: BAUSCH + LOMB ENVISTA ASPIRE HYDROPHOBIC ACRYLIC IOL; INTRAOCULAR LENS

Model Number	EA
Medical Device Problem Codes	Adverse Event Without Identified Device or Use Problem (2993); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes	Visual Impairment (2138); Toxic Anterior Segment Syndrome (TASS) (4469)
Date of Event	01/28/2025
Type of Reportable Event	Serious Injury
Additional Manufacturer Narrative
The device remains implanted and is not available for evaluation.Investigation of this event is in progress.A follow-up report will be submitted upon completion of investigation.
Event or Problem Description
It was reported that one day post an uncomplicated cataract extraction and implantation of an intraocular lens (iol) into the eye the patient¿s visual acuity was 20/30.The patient¿s visual acuity decreased over the next week and a half and the iol was observed to be white and opaque.An intraocular injection of antibiotics was administered as a precaution.One month after implant, the surgeon attempted to remove the iol, but observed an inflammatory membrane, allegedly as a result of tass, and removed the membrane.The iol was determined to be clear and remains implanted.Additional information was requested, but not received.
Event or Problem Description
Additional information received clarified that the fibrous membrane was on the anterior optic of the lens.The patient is recovering.
Additional Manufacturer Narrative
The device remains implanted and is not available for evaluation.Investigation of this event is in progress.A follow-up report will be submitted upon completion of investigation.
Additional Manufacturer Narrative
Additional information: g3, h2, h6, h7, h9, h11.The device remains implanted.Investigation of this event is in progress.Recall of device is underway.

• Brand Name: ENVISTA ASPIRE HYDROPHOBIC ACRYLIC IOL
• Common Device Name: INTRAOCULAR LENS
• Manufacturer (Section D): BAUSCH + LOMB; 1400 north goodman street; rochester NY 14609
• Manufacturer (Section G): BAUSCH + LOMB; 21 n park place blvd; clearwater FL 33759
• Manufacturer Contact: shayan habibi ; 21 n park place blvd; clearwater, FL 33759 ; 7277246600
• MDR Report Key: 21463099
• Report Number: 0001313525-2025-00020
• Device Sequence Number: 8750221
• Product Code: HQL
• UDI-Device Identifier: 10757770608604
• UDI-Public: (01)10757770608604
• Combination Product (Y/N): N
• Initial Reporter State: CA
• Initial Reporter Country: US
• PMA/510(K) Number: P910056
• Number of Events Summarized: 1
• Summary Report (Y/N): N
• Device Implanted Year: 2025
• Serviced by Third Party (Y/N): Unknown
• Reporter Type: Manufacturer
• Report Source: Health Professional,User Facility
• Initial Reporter Occupation: Physician
• Remedial Action: Recall
• Type of Report: Initial,Followup,Followup
• Report Date (Section B): 01/29/2025

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Operator of Device: Health Professional
• Device Model Number: EA
• Device Catalogue Number: EAU2250
• Device Lot Number: 3Q28049
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Type of Report(Section G): Thirty-Day
• Initial Date Received by Manufacturer: 01/29/2025
• Supplement Date Received by Manufacturer: 02/27/2025; 04/04/2025
• Initial Report FDA Received Date: 02/25/2025
• Supplement Report FDA Received Date: 03/28/2025; 04/07/2025
• Was Device Evaluated by Manufacturer? (Y/N): No
• Is the Device Labeled for Single Use? (Y/N): Yes
• Is This a Single-Use Device that was Reprocessed and Reused on a Patient? (Y/N): No
• Usage of Device: Initial
• If action reported to FDA under 21 USC 360i(g), list FDA-assigned Recall Number or include a statement: RES96594
• Patient Sequence Number: 1
• Concomitant Medical Products and Therapy/Usage Dates: BLIS-R1, BLIS-X1, TOTALVISC, BSS
• Outcome Attributed to Adverse Event: Required Intervention
• Patient Sex: Male